ACHV
Achieve Life Sciences Inc
NASDAQ: ACHV · HEALTHCARE · BIOTECHNOLOGY
$4.15
-2.81% today
Updated 2026-04-29
Market cap
$220.95M
P/E ratio
—
P/S ratio
5.09x
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$2 – $6
Volume
1.1M
Achieve Life Sciences Inc (ACHV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-257.70%
ROA
-85.30%
Debt/equity
0.30x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $22.39M | $-23.55M | 100.00% | -117.39% | -105.18% |
| 2007 | $20.13M | $-13.06M | 100.00% | -75.68% | -64.89% |
| 2008 | $20.13M | $-4.20M | 100.00% | -31.11% | -20.88% |
| 2009 | $25.54M | $5.48M | 100.00% | -9.65% | 21.44% |
| 2010 | $13.62M | $-12.58M | 100.00% | -108.29% | -92.42% |
| 2011 | $5.50M | $-14.67M | 100.00% | -405.51% | -266.98% |
| 2012 | $20.09M | $-21.10M | 100.00% | -129.32% | -104.99% |
| 2013 | $29.88M | $-31.85M | 100.00% | -118.22% | -106.58% |
| 2014 | $27.12M | $-26.24M | 100.00% | -108.67% | -96.77% |
| 2015 | $18.16M | $-16.80M | 100.00% | -103.27% | -92.52% |
| 2016 | $5.06M | $-20.13M | 100.00% | -418.65% | -397.65% |
| 2017 | $0.00 | $-10.58M | — | — | — |
| 2018 | $0.00 | $-12.69M | — | — | — |
| 2019 | $0.00 | $-16.14M | — | — | — |
| 2020 | $0.00 | $-14.66M | — | — | — |
| 2021 | $0.00 | $-32.90M | — | — | — |
| 2022 | $0.00 | $-41.88M | — | — | — |
| 2023 | $0.00 | $-29.82M | — | — | — |
| 2024 | $0.00 | $-39.83M | — | — | — |
| 2025 | $0.00 | $-54.65M | — | — | — |